Sun Pharmaceutical Industries has announced its fourth quarter results. The company's Q4FY11 revenues were up 35% to Rs 1463 crore versus Rs 1080 crore, year-on-year, YoY.
Its EBITDA was up 6% to Rs 443 crore versus Rs 418 crore.
Its OPM at 30% versus 39%.
The company's PAT was up 12% to Rs 442 crore versus Rs 394 crore.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment